Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Contrarius Global Equity Fund surged 30.9% in Q3 2025, vastly outperforming the benchmark. The manager remains highly bullish on underappreciated real-world AI themes and is aggressively backing small, unloved gene-editing biotech firms at cyclical lows.
Full Quick Take
Contrarius Global Equity Fund surged 30.9% in Q3 2025, vastly outperforming the benchmark. The manager remains highly bullish on underappreciated real-world AI themes and is aggressively backing small, unloved gene-editing biotech firms at cyclical lows.
